For expecting parents who have herpes simplex virus (HSV), questions about the safety of their baby can carry deep emotional weight. One of the most pressing concerns is whether herpes can be passed to a baby before birth—a possibility known as vertical transmission. This refers to the transmission of an infection from a pregnant person to their baby, either during pregnancy, labor and delivery, or shortly after birth.
Although the risk of in-womb HSV transmission is very low, the fear it sparks is real, and often compounded by a lack of clear public guidance. The uncertainty, especially for those newly diagnosed or unaware they carry HSV, can lead to anxiety about the health and safety of the baby. It’s a vulnerable place to be—but it’s also one where knowledge, care, and support make a difference.
This article explores how and when HSV can be transmitted from parent to baby, why in utero transmission is so rare, and the steps that can reduce risk even further. The goal isn’t to alarm, but to inform—with calm, grounded facts that empower parents to navigate their pregnancy with confidence and care.
What Is Vertical Transmission?
Vertical transmission refers to the transfer of an infection from a pregnant person to their baby. This can happen before birth during pregnancy, during the process of labor and delivery, or in the early days after birth. What sets it apart from horizontal transmission is the route. Horizontal transmission occurs between individuals who are not parent and child, such as through sexual contact or other forms of direct exposure.
In the case of herpes simplex virus (HSV), vertical transmission can occur in three distinct ways. The first is in utero, meaning the virus crosses the placenta and reaches the baby during pregnancy. This form of transmission is very rare and is usually linked to a first-time HSV infection during early pregnancy. The second, known as peripartum transmission, occurs during delivery. This is the most common time for a baby to be exposed to HSV, especially if the parent has an active infection and it is their first outbreak. Finally, postnatal transmission happens after birth, often when a baby comes into contact with someone who has an active lesion, such as a cold sore.
Understanding these three timing windows helps clarify how and when a baby might be at risk. In utero transmission is possible but accounts for only a small number of cases. The majority occur during delivery, when a baby is exposed to the virus in the birth canal. A smaller number happen after birth, often through skin-to-skin contact with infected caregivers.
Recognizing the difference between vertical and horizontal transmission, and understanding the specific ways HSV can be passed to a newborn, provides a clearer picture of what to watch for and when. While the idea of transmission can be frightening, the actual risk is low in most pregnancies, and with the right care, many of these risks can be effectively managed.
Can Herpes Cross the Placenta During Pregnancy?
Herpes simplex virus can, in rare cases, cross the placenta and reach the baby during pregnancy. This form of vertical transmission is called transplacental or in utero transmission. Though it is considered extremely uncommon, when it does happen, it can lead to a serious condition known as congenital herpes.
Most documented cases of transplacental HSV involve a first-time infection during early pregnancy. Without pre-existing immunity, the parent’s body lacks the antibodies needed to help protect the developing baby. This can allow the virus to enter the bloodstream and reach the placenta. Once the virus crosses this barrier, it may affect the fetus, potentially causing widespread inflammation and damage to the brain, skin, and internal organs.
Several case reports have shown that HSV can be passed to the fetus even when labor has not begun, including in pregnancies delivered by cesarean section with intact membranes. While these cases are rare and sometimes difficult to confirm, they underscore the possibility of hematogenous spread — where the virus travels through the blood to the placenta and beyond.
The risk is especially concerning when the initial infection happens in the first trimester. At that stage, the baby’s organ systems are forming, and any disruption can have lasting consequences. Some babies exposed in this way have been born with severe neurological conditions, such as encephalitis, hydrocephalus, or microcephaly. Others may have skin lesions or signs of systemic infection at birth. In the most serious cases, congenital herpes can be fatal if not recognized and treated immediately.
Fortunately, for parents who already have HSV and are not experiencing a new infection, the risk of transplacental transmission is significantly lower. This is because protective antibodies are transferred through the placenta and can help guard against severe outcomes. Studies have shown that babies born to parents with recurrent HSV infections typically have high levels of these antibodies and are much less likely to be affected.
While the idea of herpes crossing the placenta can be frightening, it’s important to remember that this scenario is the exception, not the rule. With prenatal care and early communication about HSV status, the chances of such an outcome can be greatly reduced.
Risk Factors for In Utero Herpes Transmission
Although in utero transmission of herpes simplex virus is rare, certain factors can increase the likelihood of it occurring. Understanding these risks is important for expecting parents and healthcare providers to take proactive steps toward prevention and early intervention.
One of the most significant risk factors is acquiring HSV for the first time during pregnancy, especially in the third trimester. When the body has not had a chance to develop antibodies, the virus can circulate more freely and increase the chance of reaching the baby. This is when the immune system’s protective mechanisms are at their weakest, and the placenta may be less effective in preventing the virus from crossing over. Most neonatal herpes cases linked to pregnancy are tied to previously undiagnosed primary infections occurring near the time of delivery.
A weakened or compromised immune system also plays a role. For individuals living with conditions like HIV, the body’s ability to control HSV is reduced. This increases the chance of viral reactivation or dissemination, which may make vertical transmission more likely. When immune function is impaired, it becomes harder to suppress the virus and prevent it from spreading through the bloodstream to the fetus.
Another rare but serious risk factor is maternal viremia, which is the presence of HSV in the bloodstream. This typically occurs only in severe or disseminated cases and is most often linked to a first-time infection. In such instances, the virus can travel through the maternal circulation and cross the placenta, leading to in utero infection. While this kind of viremia is uncommon in healthy individuals, it can present a serious risk if it does occur.
Lack of prenatal care or an unrecognized infection also contributes significantly to risk. Many pregnant individuals who transmit HSV to their babies do not know they are infected. Without early screening, counseling, or symptom awareness, it is easy for a new infection to go unnoticed until it becomes a concern near delivery. Unrecognized primary infections leave both the pregnant person and their baby more vulnerable, especially in the absence of antiviral treatment or close monitoring.
These risk factors highlight the importance of early testing, open communication with providers, and consistent prenatal care. When HSV is identified and managed, the risk of in utero transmission remains extremely low, even in the presence of complicating factors.
How Common Is Neonatal Herpes and When Does It Usually Occur?
Neonatal herpes is an uncommon but serious condition, and understanding when it typically occurs can help clarify the real risks. The vast majority of neonatal herpes cases happen during delivery, not during pregnancy. In fact, research shows that up to 86 percent of neonatal infections are acquired in the intrapartum period. This is when a baby is exposed to HSV through direct contact with infected genital secretions during labor and birth.
Transmission after birth is also possible but relatively rare. In these cases, a newborn might contract HSV through contact with a caregiver who has an active cold sore or other lesion. Preventing postnatal infection mostly comes down to good hygiene and avoiding close contact when any visible signs of infection are present.
The least common, though often most concerning, route of transmission is in utero. This occurs when HSV crosses the placenta during pregnancy. Fewer than five percent of neonatal herpes cases begin this way. When it does happen, the effects can be severe, with the virus potentially causing damage to the baby’s brain, organs, or skin. Cases of congenital herpes often involve central nervous system complications, and they typically arise from primary maternal infections earlier in pregnancy.
Although in utero cases are rare, they highlight why monitoring HSV in pregnancy is so important. If a person contracts HSV for the first time late in pregnancy, the risk of neonatal infection increases significantly, particularly if the immune system hasn’t yet produced protective antibodies. In these cases, testing and close observation become key. Polymerase chain reaction (PCR) testing and early treatment with antiviral medications like acyclovir have been shown to dramatically reduce the risk of severe outcomes.
Efforts like national surveillance programs and maternal screening protocols have helped improve early detection and management. When HSV is identified in time, steps can be taken to reduce the chance of transmission and ensure the best possible outcome for both parent and baby.
Steps to Reduce Transmission Risk During Pregnancy
There are several evidence-based steps that can significantly lower the chances of transmitting herpes simplex virus during pregnancy. These approaches are most effective when implemented early and tailored to each individual’s medical history and risk level.
One of the most important actions is to disclose your HSV status to your obstetrician or midwife as early as possible. When healthcare providers are aware, they can offer proactive monitoring, individualized birth planning, and timely use of antiviral medications. This is particularly helpful for identifying previously undiagnosed infections, which are more common than many people realize. Open communication supports early testing, which can detect asymptomatic HSV and guide preventive care.
For those who carry HSV, taking antiviral medication during the third trimester is a well-established strategy. Daily use of medications like acyclovir or valacyclovir, starting around 36 weeks, has been shown to reduce viral shedding, lower the risk of recurrent outbreaks at the time of delivery, and significantly decrease the need for cesarean delivery due to herpes. This kind of suppressive therapy is generally considered safe for both parent and baby, with very few reported side effects.
Close to the due date, careful monitoring becomes essential. A clinical exam to check for lesions is standard practice, and if there’s any doubt, lab testing can help determine whether the virus is active. If symptoms or test results suggest an active infection at the time of labor, cesarean delivery is often recommended to minimize the baby’s exposure. This recommendation is especially strong for individuals having their first HSV outbreak near the time of delivery or within the previous six weeks.
Even in the absence of symptoms, providers may choose to monitor closely and adjust the delivery plan based on personal history, timing of membrane rupture, or recent changes in medication. A cesarean delivery can reduce the risk of neonatal infection, though it does not eliminate it entirely. These decisions are best made with full information, ongoing communication, and a clear understanding of personal risk factors.
With early disclosure, routine antiviral management, and active monitoring, most pregnancies affected by HSV can progress safely. These steps help shift the focus from fear to preparation, giving families the tools they need to feel confident and supported.
What If You’re Diagnosed with Herpes During Pregnancy?
A diagnosis of genital herpes during pregnancy can feel unsettling. Many expectant parents experience a wave of emotions, from fear to confusion, especially when imagining how the virus might affect their baby. But it’s important to understand that this situation is manageable. With appropriate care and support, most people with HSV have healthy pregnancies and deliver healthy babies.
Emotional support plays a crucial role in this process. Herpes can carry stigma, and a new diagnosis during such a sensitive time may add to feelings of stress or isolation. Yet the medical reality is far more reassuring. The majority of neonatal HSV infections can be prevented. With monitoring and the use of antiviral medications, the risk of transmission is significantly reduced.
The first step after a diagnosis is to inform your obstetric provider. This opens the door to tailored care, including decisions about testing and treatment. Blood tests and viral swabs may be used to confirm whether the infection is new or recurrent. That distinction matters, as primary infections carry a higher risk of transmission than those in people who already have antibodies to the virus.
Your provider may recommend antiviral treatment, typically with a medication like acyclovir. These medications are considered safe during pregnancy when used appropriately, and they are often prescribed in the third trimester to reduce viral shedding and the likelihood of outbreaks near delivery.
Though it may not feel like it right away, a herpes diagnosis during pregnancy does not define your experience. With trusted care, information, and emotional support, you can focus on what matters most: preparing for a safe and healthy arrival.
After Birth: Keeping Baby Safe
After a baby is born, herpes simplex virus can still be a concern, particularly HSV-1, which causes cold sores. Newborns are especially vulnerable in the first few weeks of life when their immune systems are still developing. Postnatal transmission usually happens through close contact, most often from caregivers or visitors who have active cold sores on their lips or face.
Even small or subtle sores can be contagious. Something as simple as a kiss or close facial contact can pass the virus to a baby. While these actions are often affectionate, they can carry risk if HSV is present. In some cases, infants have developed serious complications, including brain inflammation and widespread infection, following exposure to HSV-1 from someone with an active lesion.
For this reason, it is important to avoid kissing a baby if you have a cold sore. This recommendation applies not only to parents but also to siblings, extended family members, and anyone else who might be near the baby. What may seem like a minor sore can lead to major consequences for a newborn.
Even in the absence of visible symptoms, transmission is still possible. Herpes can sometimes be spread before a sore fully appears, so it’s best to be cautious during any time you suspect an outbreak may be starting. Good hygiene practices, such as hand washing, avoiding face-to-face contact, and not sharing utensils, can help reduce the risk.
These precautions are not about alarm. They are about offering a layer of protection during a critical time in a baby’s early life. With a few mindful choices, families can create a safe and nurturing space while minimizing the chance of postnatal HSV exposure.
Reassurance Rooted in Knowledge
Learning about the possibility of herpes transmission during pregnancy can feel daunting, but the bigger picture offers reassurance. In utero transmission is extremely rare. With the right knowledge, medical guidance, and support, most people with herpes go on to have healthy pregnancies and babies.
Being open with your healthcare provider, understanding your risks, and taking steps like antiviral treatment or delivery planning can all make a meaningful difference. And if you’re navigating a new diagnosis, remember that you’re not alone. Many others have faced the same questions and concerns and have found clarity and peace through compassionate care and accurate information.
If this article has been helpful, we invite you to join our mailing list. You’ll receive gentle, timely updates with new articles, trusted resources, and support to guide you through pregnancy and beyond.
References
Arvin, A. (1991). Relationships between maternal immunity to herpes simplex virus and the risk of neonatal herpesvirus infection. Reviews of Infectious Diseases, 13(Suppl 11), S953–S956.
Ashley, R., Dalessio, J., Burchett, S., et al. (1992). HSV-2 Antibody Protection in Neonates. The Journal of Clinical Investigation, 90(2), 511–514.
Badell, M., & Raynor, D. (2011). Herpes Simplex Virus and Pregnancy. Postgraduate Obstetrics & Gynecology, 31, 1–6.
Bal, A., Zandotti, C., Nougairède, A., et al. (2013). Fulminant Hepatitis Due to Father-to-Newborn Transmission of Herpes Simplex Virus type 1. The Open Virology Journal, 7, 96–97.
Berardi, A., Lugli, L., Rossi, C., Laguardia, C. M., Guidotti, I., Gallo, C., & Ferrari, F. (2011). Neonatal herpes simplex virus. The Journal of Maternal-Fetal & Neonatal Medicine, 24, 88–90.
Bhatta, A. K., Keyal, U., Liu, Y., & Gellén, E. (2018). Vertical transmission of herpes simplex virus: an update. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 16.
Brkić, S., & Jovanović, J. (1998). Genital herpes with special emphasis on perinatal herpes simplex virus infection. Medicinski pregled, 51(1-2), 45–49.
Brown, Z. A., Gardella, C., Wald, A., Morrow, R. A., & Corey, L. (2005). Genital herpes complicating pregnancy. Obstetrics and gynecology, 106(4), 845–856.
Burgos, J., Ramírez, C., Guzmán-Sánchez, F., Alfaro, J., Sastre, I., & Valdivieso, F. (2006). Hematogenous Vertical Transmission of Herpes Simplex Virus Type 1 in Mice. Journal of Virology, 80(6), 2823–2831.
Calix, R. X., Loeliger, K. B., Burn, M. S., & Campbell, K. H. (2020). Acute Herpes Simplex Virus Hepatitis in Pregnancy. Obstetric Anesthesia Digest.
Centers for Disease Control and Prevention. (2012). Neonatal herpes simplex virus infection following Jewish ritual circumcisions that included direct orogenital suction. MMWR. Morbidity and Mortality Weekly Report, 61(22), 405–409.
Cherpes, T. L., Matthews, D. B., & Maryak, S. A. (2012). Neonatal herpes simplex virus infection. Clinical Obstetrics and Gynecology, 55(4), 938-944.
Clarke, E., Patel, R., Dickins, D., Fidler, K., Jackson, A., Kingston, M., Jones, C., Lyall, H., Nicholson, M., Pelosi, E., Porter, D., Powell, G., & Foley, E. (2024). Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate (2024 update). International Journal of STD & AIDS.
Drake, A. L., John-Stewart, G. C., Wald, A., Mbori-Ngacha, D., Bosire, R., Wamalwa, D., Lohman-Payne, B., Ashley-Morrow, R., Corey, L., & Farquhar, C. (2007). Herpes Simplex Virus Type 2 and Risk of Intrapartum Human Immunodeficiency Virus Transmission. Obstetrics & Gynecology, 109, 403–409.
El-Atawi, K., Elhalik, M., & Farid, A. (2016). Congenital herpes simplex type-2 infection; challenges and solutions. Journal of Clinical Neonatology, 5(3), 205.
ffrench-Constant, S., Ramji, S., Lyall, H., Randell, P., & Jan, W. (2020). Intra‐uterine herpes simplex transmission with devastating central nervous system sequelae. Journal of Paediatrics and Child Health, 57.
Forsgren, M., & Malm, G. (1996). Herpes simplex virus and pregnancy. Scandinavian Journal of Infectious Diseases. Supplementum, 100, 14–19.
Freij, B. (2004). Management of Neonatal herpes simplex virus infections. The Indian Journal of Pediatrics, 71, 921–926.
Gardella, C., Brown, Z. A., Wald, A., Selke, S., Zeh, J., Morrow, R. A., & Corey, L. (2006). Risk factors for herpes simplex virus transmission to pregnant women: A couples study. Obstetrical & Gynecological Survey, 61, 360–362.
Guleria, K., & Sethi, N. (2020). Herpes in Pregnancy. Journal of Fetal Medicine, 7, 49–55.
Hammad, W., & Konje, J. (2021). Herpes simplex virus infection in pregnancy – An update. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 259, 38–45.
Hitti, J., et al. (1997). Herpes simplex virus seropositivity and reactivation at delivery among pregnant women infected with human immunodeficiency virus-1. American Journal of Obstetrics and Gynecology, 177(2), 450–454.
Hollier, L., & Wendel, G. (2008). Third trimester antiviral prophylaxis for preventing maternal genital herpes simplex virus (HSV) recurrences and neonatal infection. Cochrane Database of Systematic Reviews, 1, CD004946.
Hribernik, I., Dragoš, V., & Cerar, L. K. (2019). Intrauterine herpes simplex virus type one infection presenting with skin erosions and ulcers: Masking as neonatal sepsis. Journal of Clinical Neonatology, 8, 54–56.
Jones, C. A. (2012). Vertical Transmission of Genital Herpes. Drugs, 69(4), 421–434.
Kriebs, J. M. (2008). Understanding herpes simplex virus: transmission, diagnosis, and considerations in pregnancy management. Journal of Midwifery & Women’s Health, 53(3), 202–208.
Kropp, R., Wong, T., Cormier, L., Ringrose, A., Burton, S., Embree, J., & Steben, M. (2006). Neonatal Herpes Simplex Virus Infections in Canada: Results of a 3-Year National Prospective Study. Pediatrics, 117, 1955–1962.
Lee, A., Bar-Zeev, N., Walker, S., & Permezel, M. (2003). In Utero Herpes Simplex Encephalitis. Obstetrics & Gynecology, 102(6), 1197–1199.
Matos, R., Pires, J., & Cortesão, D. (2016). Management of Neonatal Herpes Simplex Infection: A Rare Case of Blepharoconjunctivitis and Concurrent Epithelial and Stromal Keratitis. Ocular Immunology and Inflammation, 26, 625–627.
Mercolini, F., Verdi, F., Eisendle, K., Messner, H., & Staffler, A. (2014). Congenital Disseminated HSV-1 Infection in Preterm Twins. Zeitschrift für Geburtshilfe und Neonatologie, 218, 261–264.
Nechekhova, O.A., Pavlyuchenko, V.V., & Batman, Y. (2022). Clinical Case of Congenital Herpesvirus Infection from Asymptomatic Maternal HSV-2. Neonatology, Surgery and Perinatal Medicine.
Pasternak, B., & Hviid, A. (2010). Use of acyclovir, valacyclovir, and famciclovir in the first trimester of pregnancy and the risk of birth defects. JAMA, 304(8), 859–866.
Pittet, L., & Curtis, N. (2020). Postnatal Exposure to Herpes Simplex Virus: To Treat or Not to Treat? Pediatric Infectious Disease Journal.
Roberts, S. (2009). Herpes simplex virus: incidence of neonatal herpes, maternal screening, management during pregnancy, and HIV. Current Opinion in Obstetrics and Gynecology, 21, 124–130.
Saini, A., Patodia, J., & Mittal, J. (2021). A Preterm With Disseminated Neonatal Herpes Simplex Virus (HSV) After Kangaroo Mother Care. Journal of Neonatology, 35, 242–245.
Sánchez Pujol, M. J., Docampo Simón, A., Sanguino, L., Blanes, M., & Betlloch, I. (2022). Herpes simplex virus infection in neonates born to asymptomatic mothers: A case series. Cureus, 14.
Sauerbrei, A., & Wutzler, P. (2006). Herpes simplex and varicella-zoster virus infections during pregnancy. Medical Microbiology and Immunology, 196(2), 89–94.
Scott, L., Sánchez, P., Jackson, G., Zeray, F., & Wendel, G. (1996). Acyclovir Suppression to Prevent Cesarean Delivery After First‐Episode Genital Herpes. Obstetrics & Gynecology, 87(1), 69–73.
Sénat, M. V., Anselem, O., Picone, O., Renesme, L., Sananès, N., Vauloup-Fellous, C., Sellier, Y., Laplace, J. P., & Sentilhes, L. (2018). Prevention and management of genital herpes simplex infection during pregnancy and delivery: Guidelines from the French College of Gynaecologists and Obstetricians (CNGOF). European journal of obstetrics, gynecology, and reproductive biology, 224, 93–101.
Sheffield, J., et al. (2003). Acyclovir Prophylaxis to Prevent Herpes Simplex Virus Recurrence at Delivery: A Systematic Review. Obstetrics & Gynecology, 102, 1396–1403.
Shiraki, K., Daikoku, T., Prichard, M.N., Matsuo, K., Okuda, T., Yoshida, Y., Takemoto, M., Takeuchi, K., Sada, K., Whitley, R., & Kawana, T. (2024). Vertical mother‐to‐infant transmission of herpes simplex virus 2 is correlated with tropism due to mutations in viral UL13. Journal of Medical Virology, 96.
Sloan, J., Cawyer, C. C., & Drever, N. S. (2017). Fetal Ventriculomegaly and Herpes Encephalitis Following Primary Maternal HSV Infection. Baylor University Medical Center Proceedings, 30, 463–464.
Srivastava, H. K., Ellis, L. T., Miller, D. C., & Duff, D. (2020). Herpes in the Heart: A Case of Widely Disseminated Intrauterine Herpes Simplex Virus Infection. Case Reports in Infectious Diseases, 2020.
Stankiewicz Karita, H. S., et al. (2017). Invasive Obstetric Procedures and Cesarean Sections in Women With Known Herpes Simplex Virus Status During Pregnancy. Open Forum Infectious Diseases, 4(4).
Stephenson-Famy, A., & Gardella, C. (2014). Herpes simplex virus infection during pregnancy. Obstetrics and gynecology clinics of North America, 41(4), 601–614.
Straface, G., et al. (2012). Herpes Simplex Virus Infection in Pregnancy. Infectious Diseases in Obstetrics and Gynecology, 2012.
Suzuki S. (2023). Transmission of the Herpes Simplex Virus in the Preclinical Phase of Disease Progression during Childbirth. JMA journal, 6(2), 223–225.
Westhoff, G., Little, S., & Caughey, A. (2011). Herpes Simplex Virus and Pregnancy: A Review of the Management of Antenatal and Peripartum Herpes Infections. Obstetrical & Gynecological Survey, 66(10), 629–638.
Witzleben, C., & Driscoll, S. (1965). Possible Transplacental Transmission of Herpes Simplex. Pediatrics, 36(2), 192–199.
Yeager, A., Arvin, A., Urbani, L., & Kemp, J. (1980). Antibody and Neonatal HSV Outcome. Infection and Immunity, 29(2), 532–538.
